Lonza Group AG

LONN.SW · Moat type: UNBESTIMMT

MoatScore

2/10

Fair Value

392 CHF (≈ 488.44 USD)

Margin of Safety

-46.4 %

Rating

MEIDEN

GESCHÄFTSMODELL Lonza Group is a leading contract development and manufacturing organization (CDMO) for the pharmaceutical and biotech industry, which develops and manufactures active pharmaceutical ingredients, biologics, and cell/gene therapies on behalf of pharmaceutical companies.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.